Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,519 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0-2+) metastatic breast cancer.
Lum LG, Al-Kadhimi Z, Deol A, Kondadasula V, Schalk D, Tomashewski E, Steele P, Fields K, Giroux M, Liu Q, Flaherty L, Simon M, Thakur A. Lum LG, et al. Among authors: simon m. J Immunother Cancer. 2021 Jun;9(6):e002194. doi: 10.1136/jitc-2020-002194. J Immunother Cancer. 2021. PMID: 34117114 Free article.
5,519 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page